Pallas Health review

By Marcus HaleLongevity Research Editor
Updated August 2026

Publishes both NAD+ ladders in full, and sells no month

The injection and the nasal spray each carry a reduced first month and then a twelve-week block — the per-month figure beside them is an average of that block, not a rung you can buy.

$189–$199/mo avg

We may earn a commission if you sign up through our links, at no cost to you. How we make money.

View Pallas Health

Key details

Advertised price: "NAD+ nasal spray $79 first month* then $189/mo avg" and "NAD+ injection $89 first month* then $199/mo avg", shown as plan cards on Pallas's NAD+ treatment page.
Billing details: There is no monthly rate. In Pallas's own words: "Nasal spray: $79 for your first month, then $567 every 12 weeks ($189/mo average). Injection: $89 for your first month, then $597 every 12 weeks ($199/mo average)." The $189 and $199 are averages of a block, not prices.
Pharmacy: Not named. Pallas states it "does not manufacture or compound medication" and that compounding is done by "US-licensed compounding pharmacies" — plural and generic — and no 503A or 503B classification appears anywhere.
Availability: No state list is published on the public site for the NAD+ line.
Comparison: Listed on our NAD+ provider index.

Our verdict

Pallas Health is clear about price and awkward about billing at the same time. It publishes its NAD+ pricing properly: both routes, the first-month rate and the recurring charge, on the treatment page, before any intake — which many NAD+ sellers do not do. What it does not sell is a month. After the discounted first month the only option is a twelve-week block paid up front, and the per-month figures beside it are Pallas's own division of that block. That matters for budgeting, because twelve weeks is not a quarter: a year holds 4.33 of those cycles, so the annual cost lands above four times the block and the monthly average quietly understates it. One more thing before you start: the NAD+ sign-up flow opens straight into goal questions with no price anywhere, so if you begin there you never see the prices at all. The plan price does cover clinician care, check-ins and messaging with no separate membership, and nothing ships unless a clinician prescribes.

NAD+ evidence

Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route.

Pricing and fees

Advertised price: "NAD+ nasal spray $79 first month* then $189/mo avg" and "NAD+ injection $89 first month* then $199/mo avg", shown as plan cards on Pallas's NAD+ treatment page.
Payment terms: There is no monthly rate. In Pallas's own words: "Nasal spray: $79 for your first month, then $567 every 12 weeks ($189/mo average). Injection: $89 for your first month, then $597 every 12 weeks ($199/mo average)." The $189 and $199 are averages of a block, not prices.
Pricing details: The billing cycle. Twelve weeks is not three months — a year takes 4.33 blocks — so both averages understate the calendar-month cost. And where you start matters: the NAD+ treatment page shows every price, while the NAD+ sign-up flow opens into goal questions with no figure at all, so you may never see a price before the intake.

Additional fees

No separate membership fee — the plan price is stated as covering clinician care, ongoing check-ins and care-team messaging
Auto-renews unless canceled, and cancellation is stated as available at any time
Ships in roughly a week, and only if a clinician prescribes

Prices are from Pallas Health's own website and can change without notice.

Who it may suit

May suit you if

You want the whole NAD+ price published before you hand over anything, including the recurring charge rather than only an intro rate
You want a nasal option priced genuinely below the injection rather than at the same figure
You are comfortable paying a quarter at a time
You want clinician care and messaging inside the price rather than as a membership

Consider another option if

You want a month-to-month plan you can stop after one cycle — there is no monthly rung here at all
You budget by calendar month: a twelve-week cycle is 4.33 charges a year, so the advertised average is below your real monthly cost
You want to know which pharmacy compounds it — none is named, and no 503A or 503B classification appears
You want human trial evidence for the route; no prescription NAD+ has it, this one included

What’s included

Consultation: Yes — a US-licensed clinician reviews an online intake, and medication ships only if prescribed.
Lab testing: Not required, and no lab gate is published, so no baseline NAD+ level is measured.
Follow-up care: Ongoing check-ins and care-team messaging are stated as inside the plan price, with no per-visit charge published.
Clinical support: Care-team messaging is included; no nurse or dietitian tier is advertised separately.
Supplies: Ships ready to use after approval.
Shipping: Included, stated as roughly one week.

Limitations and policy details

It sells twelve-week blocks, not months, and then quotes you a monthly average. Every figure on the plan card is an average of a block paid up front, and because a year holds 4.33 of those blocks rather than four, even that average understates what a calendar year costs. After the first month, there is no single-month option at all.

Other considerations

There is no monthly option — after the discounted first month the only choice is a twelve-week block paid up front, $567 for the nasal spray or $597 for the injection
A twelve-week cycle is 4.33 charges a year rather than 4, so both advertised per-month averages sit below what a calendar year actually costs
Where you start decides whether you see a price: the NAD+ treatment page shows every price, while the NAD+ sign-up flow opens into goal questions with no figure anywhere
No compounding pharmacy is named and no 503A or 503B classification appears — Pallas states only that compounding is done by "US-licensed compounding pharmacies"
The first-month rate is an intro price, not the standing one; the block is what recurs
No state list is published on the public site for the NAD+ line
Compounded NAD+ is not an FDA-approved product and does not have established clinical benefits for routine energy, focus or healthy aging

Cost calculators

NAD+ therapy cost calculator

How this site makes money

We may earn a commission when you buy a product or start care through our links, at no extra cost to you. Affiliate partners appear first in our provider comparison. Read the full disclosure.

View Pallas Health

Every figure on this page comes from Pallas Health’s own site, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.